MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
15.34
+1.02 (7.12%)
At close: Dec 16, 2025, 4:00 PM EST
15.34
0.00 (0.01%)
After-hours: Dec 16, 2025, 7:55 PM EST
MLTX Market Cap
MLTX has a market cap or net worth of $1.09 billion as of December 16, 2025. Its market cap has decreased by -67.99% in one year.
Market Cap
1.09B
Enterprise Value
790.12M
1-Year Change
-67.99%
Ranking
Category
Stock Price
$15.34
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $1.09B, an increase of 30,329.31%. That is a compound annual growth rate of 344.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 1.02B | -70.07% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |